We consider each medicine against agreed criteria and clinical experts are consulted to assess clinical need and suitability for the One Wales Medicines process. The All Wales Medicines Strategy Group (AWMSG) Steering Committee makes the final decision whether the medicine should proceed for a One Wales decision.
We welcome suggestions for medicines to be considered via the One Wales Medicines process from Individual Patient Funding Request (IPFR) panels, Welsh Health Specialised Services Committee (WHSSC), clinicians (ideally through clinical networks), chief pharmacists, formulary pharmacists or medicines and therapeutics committees.
The process is driven by identification of unmet clinical need by the service and therefore we cannot accept requests from pharmaceutical companies or from members of the public. To submit a request for a medicine to be considered for the One Wales process please complete a medicine request form.
Please see the One Wales Medicines process page for more details about the One Wales process including the current work programme and a list of medicines not considered suitable for inclusion.